Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Papasavvas

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current HIV Research|March 30, 2004
Lessons learned from HIV treatment interruption: safety, correlates of immune control, and drug sparingLivio Azzoni, Emmanouil Papasavvas, Luis J Montaner
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunityLivio Azzoni, Emmanouil Papasavvas, Jihed Chehimi, et al.
Antiviral Therapy|February 4, 2012
Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjectsEmmanouil Papasavvas, Priscilla Hsue, Griffin Reynolds, et al.
Plos One|December 17, 2015
Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal DatasetLivio Azzoni, Russell Barbour, Emmanouil Papasavvas, et al.
European Journal of Immunology|June 4, 2021
Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWHCostin Tomescu, Kyle Kroll, Krystal Colon, et al.
AIDS Research and Human Retroviruses|September 16, 2008
HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjectsEmmanouil Papasavvas, Elizabeth C Moore, Junwei Sun, et al.
Cancer Medicine|June 12, 2021
Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic reviewDavid S Lakomy, Juliana Wu, Dorothy Lombe, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
BACH2-driven tissue resident memory programs promote HIV-1 persistenceYulong Wei, Haocong Katherine Ma, Michelle E Wong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individualsJihed Chehimi, Donald E Campbell, Livio Azzoni, et al.
Immunology|February 17, 2015
Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patientsEmmanouil Papasavvas, Andrea Foulkes, Xiangfan Yin, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current HIV Research|March 30, 2004
Lessons learned from HIV treatment interruption: safety, correlates of immune control, and drug sparingLivio Azzoni, Emmanouil Papasavvas, Luis J Montaner
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunityLivio Azzoni, Emmanouil Papasavvas, Jihed Chehimi, et al.
Antiviral Therapy|February 4, 2012
Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjectsEmmanouil Papasavvas, Priscilla Hsue, Griffin Reynolds, et al.
Plos One|December 17, 2015
Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal DatasetLivio Azzoni, Russell Barbour, Emmanouil Papasavvas, et al.
European Journal of Immunology|June 4, 2021
Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWHCostin Tomescu, Kyle Kroll, Krystal Colon, et al.
AIDS Research and Human Retroviruses|September 16, 2008
HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjectsEmmanouil Papasavvas, Elizabeth C Moore, Junwei Sun, et al.
Cancer Medicine|June 12, 2021
Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic reviewDavid S Lakomy, Juliana Wu, Dorothy Lombe, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
BACH2-driven tissue resident memory programs promote HIV-1 persistenceYulong Wei, Haocong Katherine Ma, Michelle E Wong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individualsJihed Chehimi, Donald E Campbell, Livio Azzoni, et al.
Immunology|February 17, 2015
Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patientsEmmanouil Papasavvas, Andrea Foulkes, Xiangfan Yin, et al.
Pageof 6